(Total Views: 1191)
Posted On: 11/14/2020 10:34:01 PM
Post# of 151837
Leronlimab Treatment Inhibits CCR5 in Critically Ill COVID-19 Patients--Decreasing Inflammatory Cytokines, Increasing CD8 T-Cells, and Decreasing SARS-CoV-2 RNA in Plasma by Day 14
http://www.bioquicknews.com/node/5726?fbclid=...adhlXb6JYs
http://www.bioquicknews.com/node/5726?fbclid=...adhlXb6JYs
(2)
(0)Scroll down for more posts ▼
